In the last 12 months, insiders at LEXICON PHARMACEUTICALS, INC. ($LXRX) filed 380 transactions with the SEC: 24 open-market purchases totaling $76,586,010 and 0 sales totaling $0. Net insider sentiment: net buying.
LEXICON PHARMACEUTICALS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Artal International S.C.A. (Not found) — 4 transactions totaling $249,750,074
- Artal International S.C.A. (Director) — 1 transaction totaling $72,215,130
- Invus Global Management, LLC (Not found) — 4 transactions totaling $54,984,433
- Artal Participations S.a r.l. (Not found) — 1 transaction totaling $2,683,823
- DEBBANE RAYMOND (Director) — 22 transactions totaling $1,826,581
View all SEC Filings for LEXICON PHARMACEUTICALS, INC. (LXRX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | Exton Michael | Chief Executive Officer | M | Common Stock | 503263 | $0.00 | 503,263.0000 | 365,780,799 | 9999.99% | 0.14% |
| Feb. 28, 2026 | Exton Michael | Chief Executive Officer | M | Restricted Stock Units | 503263 | $0.00 | 1,006,527.0000 | 365,780,799 | 33.33% | 0.14% |
| Feb. 28, 2026 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | M | Common Stock | 67090 | $0.00 | 67,090.0000 | 365,780,799 | 9999.99% | 0.02% |
| Feb. 28, 2026 | McDermott Wendy | SVP, Human Resources | M | Restricted Stock Units | 144393 | $0.00 | 288,787.0000 | 365,780,799 | 33.33% | 0.04% |
| Feb. 28, 2026 | McDermott Wendy | SVP, Human Resources | M | Restricted Stock Units | 52316 | $0.00 | 52,317.0000 | 365,780,799 | 50.00% | 0.01% |
| Feb. 28, 2026 | McDermott Wendy | SVP, Human Resources | M | Restricted Stock Units | 27697 | $0.00 | 0.0000 | 365,780,799 | 100.00% | 0.01% |
| Feb. 28, 2026 | McDermott Wendy | SVP, Human Resources | F | Common Stock | 68107 | $1.47 | 277,945.0000 | 365,780,799 | 19.68% | 0.02% |
| Feb. 28, 2026 | McDermott Wendy | SVP, Human Resources | M | Common Stock | 144393 | $0.00 | 346,052.0000 | 365,780,799 | 71.60% | 0.04% |
| Feb. 28, 2026 | McDermott Wendy | SVP, Human Resources | M | Common Stock | 52316 | $0.00 | 201,659.0000 | 365,780,799 | 35.03% | 0.01% |
| Feb. 28, 2026 | McDermott Wendy | SVP, Human Resources | M | Common Stock | 27697 | $0.00 | 149,343.0000 | 365,780,799 | 22.77% | 0.01% |
| Feb. 28, 2026 | Coiante Scott M | SVP, Chief Financial Officer | M | Restricted Stock Units | 160237 | $0.00 | 320,473.0000 | 365,780,799 | 33.33% | 0.04% |
| Feb. 28, 2026 | Exton Michael | Chief Executive Officer | F | Common Stock | 204831 | $1.47 | 298,432.0000 | 365,780,799 | 40.70% | 0.06% |
| Feb. 28, 2026 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | M | Restricted Stock Units | 67090 | $0.00 | 134,180.0000 | 365,780,799 | 33.33% | 0.02% |
| Feb. 28, 2026 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | F | Common Stock | 35826 | $1.47 | 31,264.0000 | 365,780,799 | 53.40% | 0.01% |
| Feb. 28, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 35790 | $0.00 | 156,042.0000 | 365,780,799 | 29.76% | 0.01% |
| Feb. 28, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 74226 | $0.00 | 230,268.0000 | 365,780,799 | 47.57% | 0.02% |
| Feb. 28, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 202260 | $0.00 | 432,528.0000 | 365,780,799 | 87.84% | 0.06% |
| Feb. 28, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | F | Common Stock | 109098 | $1.47 | 323,430.0000 | 365,780,799 | 25.22% | 0.03% |
| Feb. 28, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 35790 | $0.00 | 0.0000 | 365,780,799 | 100.00% | 0.01% |
| Feb. 28, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 74226 | $0.00 | 74,227.0000 | 365,780,799 | 50.00% | 0.02% |
| Feb. 28, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 202260 | $0.00 | 404,520.0000 | 365,780,799 | 33.33% | 0.06% |
| Feb. 28, 2026 | Gopinathan Suma | SVP, Discovery | M | Common Stock | 14000 | $0.00 | 88,520.0000 | 365,780,799 | 18.79% | 0.00% |
| Feb. 28, 2026 | Gopinathan Suma | SVP, Discovery | M | Common Stock | 20310 | $0.00 | 108,830.0000 | 365,780,799 | 22.94% | 0.01% |
| Feb. 28, 2026 | Gopinathan Suma | SVP, Discovery | M | Common Stock | 65640 | $0.00 | 174,470.0000 | 365,780,799 | 60.31% | 0.02% |
| Feb. 28, 2026 | Gopinathan Suma | SVP, Discovery | F | Common Stock | 24338 | $1.47 | 150,132.0000 | 365,780,799 | 13.95% | 0.01% |
| Feb. 28, 2026 | Gopinathan Suma | SVP, Discovery | M | Restricted Stock Units | 14000 | $0.00 | 0.0000 | 365,780,799 | 100.00% | 0.00% |
| Feb. 28, 2026 | Gopinathan Suma | SVP, Discovery | M | Restricted Stock Units | 20310 | $0.00 | 20,310.0000 | 365,780,799 | 50.00% | 0.01% |
| Feb. 28, 2026 | Gopinathan Suma | SVP, Discovery | M | Restricted Stock Units | 65640 | $0.00 | 131,280.0000 | 365,780,799 | 33.33% | 0.02% |
| Feb. 28, 2026 | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Common Stock | 24674 | $0.00 | 40,251.0000 | 365,780,799 | 158.40% | 0.01% |
| Feb. 28, 2026 | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Common Stock | 128190 | $0.00 | 168,441.0000 | 365,780,799 | 318.48% | 0.04% |
| Feb. 28, 2026 | DeFrancesco Lisa | SVP, IR and Corp Comm | F | Common Stock | 74572 | $1.47 | 93,869.0000 | 365,780,799 | 44.27% | 0.02% |
| Feb. 28, 2026 | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Restricted Stock Units | 24674 | $0.00 | 24,673.0000 | 365,780,799 | 50.00% | 0.01% |
| Feb. 28, 2026 | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Restricted Stock Units | 128190 | $0.00 | 256,380.0000 | 365,780,799 | 33.33% | 0.04% |
| Feb. 28, 2026 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 33457 | $0.00 | 363,658.0000 | 365,780,799 | 10.13% | 0.01% |
| Feb. 28, 2026 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 69386 | $0.00 | 330,201.0000 | 365,780,799 | 26.60% | 0.02% |
| Feb. 28, 2026 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 170163 | $0.00 | 533,821.0000 | 365,780,799 | 46.79% | 0.05% |
| Feb. 28, 2026 | Crum Brian T | SVP, General Counsel & Secr. | F | Common Stock | 105019 | $1.47 | 428,802.0000 | 365,780,799 | 19.67% | 0.03% |
| Feb. 28, 2026 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 69386 | $0.00 | 69,387.0000 | 365,780,799 | 50.00% | 0.02% |
| Feb. 28, 2026 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 33457 | $0.00 | 0.0000 | 365,780,799 | 100.00% | 0.01% |
| Feb. 28, 2026 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 170163 | $0.00 | 340,327.0000 | 365,780,799 | 33.33% | 0.05% |
| Feb. 28, 2026 | Coiante Scott M | SVP, Chief Financial Officer | M | Common Stock | 160237 | $0.00 | 160,237.0000 | 365,780,799 | 9999.99% | 0.04% |
| Feb. 28, 2026 | Coiante Scott M | SVP, Chief Financial Officer | F | Common Stock | 54881 | $1.47 | 105,356.0000 | 365,780,799 | 34.25% | 0.02% |
| Feb. 25, 2026 | DEBBANE RAYMOND | Director | P | Common Stock | 2000 | $1.49 | 51,660,909.0000 | 365,780,799 | 0.00% | 0.00% |
| Feb. 23, 2026 | DEBBANE RAYMOND | Director | P | Common Stock | 100000 | $1.47 | 51,658,909.0000 | 365,780,799 | 0.19% | 0.03% |
| Feb. 20, 2026 | DEBBANE RAYMOND | Director | P | Common Stock | 100000 | $1.48 | 51,558,909.0000 | 365,780,799 | 0.19% | 0.03% |
| Feb. 19, 2026 | DEBBANE RAYMOND | Director | P | Common Stock | 50000 | $1.44 | 51,458,909.0000 | 365,780,799 | 0.10% | 0.01% |
| Feb. 17, 2026 | Artal Participations S.a r.l. | Not found | A | Series B Convertible Preferred Stock | 41290 | $65.00 | 408,434.7000 | 365,780,799 | 11.25% | 0.01% |
| Feb. 13, 2026 | DEBBANE RAYMOND | Director | P | Common Stock | 57952 | $1.31 | 51,198,364.0000 | 365,780,799 | 0.11% | 0.02% |
| Feb. 17, 2026 | DEBBANE RAYMOND | Director | P | Common Stock | 76857 | $1.31 | 51,275,221.0000 | 365,780,799 | 0.15% | 0.02% |
| Feb. 18, 2026 | DEBBANE RAYMOND | Director | P | Common Stock | 133688 | $1.32 | 51,408,909.0000 | 365,780,799 | 0.26% | 0.04% |
| Feb. 12, 2026 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | A | Restricted Stock Units | 193740 | $0.00 | 193,740.0000 | 365,780,799 | 9999.99% | 0.05% |
| Feb. 12, 2026 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | A | Stock Option (Right to Buy) | 290620 | $0.00 | 290,620.0000 | 365,780,799 | 9999.99% | 0.08% |
| Feb. 12, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | A | Restricted Stock Units | 346610 | $0.00 | 346,610.0000 | 365,780,799 | 9999.99% | 0.09% |
| Feb. 12, 2026 | Granowitz Craig B | SVP, Chief Medical Officer | A | Stock Option (Right to Buy) | 519920 | $0.00 | 519,920.0000 | 365,780,799 | 9999.99% | 0.14% |
| Feb. 12, 2026 | Gopinathan Suma | SVP, Discovery | A | Restricted Stock Units | 238450 | $0.00 | 238,450.0000 | 365,780,799 | 9999.99% | 0.07% |
| Feb. 12, 2026 | Gopinathan Suma | SVP, Discovery | A | Stock Option (Right to Buy) | 357680 | $0.00 | 357,680.0000 | 365,780,799 | 9999.99% | 0.10% |
| Feb. 12, 2026 | Crum Brian T | SVP, General Counsel & Secr. | A | Restricted Stock Units | 299710 | $0.00 | 299,710.0000 | 365,780,799 | 9999.99% | 0.08% |
| Feb. 12, 2026 | DeFrancesco Lisa | SVP, IR and Corp Comm | A | Restricted Stock Units | 257530 | $0.00 | 257,530.0000 | 365,780,799 | 9999.99% | 0.07% |
| Feb. 12, 2026 | McDermott Wendy | SVP, Human Resources | A | Restricted Stock Units | 250200 | $0.00 | 250,200.0000 | 365,780,799 | 9999.99% | 0.07% |
| Feb. 12, 2026 | McDermott Wendy | SVP, Human Resources | A | Stock Option (Right to Buy) | 375300 | $0.00 | 375,300.0000 | 365,780,799 | 9999.99% | 0.10% |
| Feb. 12, 2026 | Coiante Scott M | SVP, Chief Financial Officer | A | Stock Option (Right to Buy) | 409020 | $0.00 | 409,020.0000 | 365,780,799 | 9999.99% | 0.11% |
| Feb. 12, 2026 | Coiante Scott M | SVP, Chief Financial Officer | A | Restricted Stock Units | 272680 | $0.00 | 272,680.0000 | 365,780,799 | 9999.99% | 0.07% |
| Feb. 12, 2026 | Crum Brian T | SVP, General Counsel & Secr. | A | Stock Option (Right to Buy) | 449560 | $0.00 | 449,560.0000 | 365,780,799 | 9999.99% | 0.12% |
| Feb. 12, 2026 | DeFrancesco Lisa | SVP, IR and Corp Comm | A | Stock Option (Right to Buy) | 386300 | $0.00 | 386,300.0000 | 365,780,799 | 9999.99% | 0.11% |
| Feb. 12, 2026 | Exton Michael | Chief Executive Officer | A | Stock Option (Right to Buy) | 1293670 | $0.00 | 1,293,670.0000 | 365,780,799 | 9999.99% | 0.35% |
| Feb. 12, 2026 | Exton Michael | Chief Executive Officer | A | Restricted Stock Units | 862440 | $0.00 | 862,440.0000 | 365,780,799 | 9999.99% | 0.24% |
| Feb. 2, 2026 | Invus Global Management, LLC | Not found | A | Series B Convertible Preferred Stock | 367145 | $65.00 | 367,145.1200 | 365,780,799 | 9999.99% | 0.10% |
| Feb. 2, 2026 | Invus Global Management, LLC | Not found | P | Common Stock | 1538462 | $1.30 | 43,778,044.0000 | 365,780,799 | 3.64% | 0.42% |
| Feb. 2, 2026 | Invus Global Management, LLC | Not found | A | Common Stock | 3846154 | $1.30 | 49,601,950.0000 | 365,780,799 | 8.41% | 1.05% |
| Feb. 2, 2026 | Invus Global Management, LLC | Not found | A | Common Stock | 18553846 | $1.30 | 196,973,909.0000 | 365,780,799 | 10.40% | 5.07% |
| June 3, 2025 | DEBBANE RAYMOND | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| June 3, 2025 | Swain Judith L | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| June 3, 2025 | Swain Judith L | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| June 3, 2025 | Sullivan Diane E. | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| June 3, 2025 | Sullivan Diane E. | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| June 3, 2025 | SOBECKI CHRISTOPHER J | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| June 3, 2025 | SOBECKI CHRISTOPHER J | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| June 3, 2025 | Cheung Ivan | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| June 3, 2025 | Cheung Ivan | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| June 3, 2025 | BARKER SAM L | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| June 3, 2025 | BARKER SAM L | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| June 3, 2025 | Amouyal Philippe | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| June 3, 2025 | Amouyal Philippe | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| June 3, 2025 | DEBBANE RAYMOND | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| May 13, 2025 | BARKER SAM L | Director | M | Restricted Stock Units | 36810 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| May 13, 2025 | Swain Judith L | Director | M | Common Stock | 36810 | $0.00 | 85,174.0000 | 363,020,303 | 76.11% | 0.01% |
| May 13, 2025 | Swain Judith L | Director | M | Restricted Stock Units | 36810 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| May 13, 2025 | Sullivan Diane E. | Director | M | Common Stock | 36810 | $0.00 | 36,810.0000 | 363,020,303 | 9999.99% | 0.01% |
| May 13, 2025 | Sullivan Diane E. | Director | M | Restricted Stock Units | 36810 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| May 13, 2025 | SOBECKI CHRISTOPHER J | Director | M | Common Stock | 36810 | $0.00 | 203,865.0000 | 363,020,303 | 22.03% | 0.01% |
| May 13, 2025 | SOBECKI CHRISTOPHER J | Director | M | Restricted Stock Units | 36810 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| May 13, 2025 | BARKER SAM L | Director | M | Common Stock | 36810 | $0.00 | 124,459.0000 | 363,020,303 | 42.00% | 0.01% |
| May 13, 2025 | DEBBANE RAYMOND | Director | M | Restricted Stock Units | 36810 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| May 13, 2025 | DEBBANE RAYMOND | Director | M | Common Stock | 36810 | $0.00 | 45,755,796.0000 | 363,020,303 | 0.08% | 0.01% |
| May 13, 2025 | Amouyal Philippe | Director | M | Restricted Stock Units | 36810 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| May 13, 2025 | Amouyal Philippe | Director | M | Common Stock | 36810 | $0.00 | 285,174.0000 | 363,020,303 | 14.82% | 0.01% |
| Feb. 28, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 27917 | $0.00 | 75,543.0000 | 363,020,303 | 58.62% | 0.01% |
| Feb. 28, 2025 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 10617 | $0.00 | 58,417.0000 | 363,020,303 | 22.21% | 0.00% |
| Feb. 28, 2025 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 15926 | $0.00 | 74,343.0000 | 363,020,303 | 27.26% | 0.00% |
| Feb. 28, 2025 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 19887 | $0.00 | 94,230.0000 | 363,020,303 | 26.75% | 0.01% |
| Feb. 28, 2025 | Alexander Kristen | VP, Finance and Accounting | F | Common Stock | 17862 | $0.67 | 76,368.0000 | 363,020,303 | 18.96% | 0.00% |
| Feb. 28, 2025 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 10617 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.00% |
| Feb. 28, 2025 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 15926 | $0.00 | 15,927.0000 | 363,020,303 | 50.00% | 0.00% |
| Feb. 28, 2025 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 19887 | $0.00 | 39,773.0000 | 363,020,303 | 33.33% | 0.01% |
| Feb. 28, 2025 | McDermott Wendy | SVP, Human Resources | M | Common Stock | 18943 | $0.00 | 71,637.0000 | 363,020,303 | 35.95% | 0.01% |
| Feb. 28, 2025 | McDermott Wendy | SVP, Human Resources | M | Common Stock | 27696 | $0.00 | 99,333.0000 | 363,020,303 | 38.66% | 0.01% |
| Feb. 28, 2025 | McDermott Wendy | SVP, Human Resources | M | Common Stock | 52317 | $0.00 | 151,650.0000 | 363,020,303 | 52.67% | 0.01% |
| Feb. 28, 2025 | McDermott Wendy | SVP, Human Resources | F | Common Stock | 30004 | $0.67 | 121,646.0000 | 363,020,303 | 19.79% | 0.01% |
| Feb. 28, 2025 | McDermott Wendy | SVP, Human Resources | M | Restricted Stock Units | 18943 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| Feb. 28, 2025 | McDermott Wendy | SVP, Human Resources | M | Restricted Stock Units | 27696 | $0.00 | 27,697.0000 | 363,020,303 | 50.00% | 0.01% |
| Feb. 28, 2025 | McDermott Wendy | SVP, Human Resources | M | Restricted Stock Units | 52317 | $0.00 | 104,633.0000 | 363,020,303 | 33.33% | 0.01% |
| Feb. 28, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 25667 | $0.00 | 281,391.0000 | 363,020,303 | 10.04% | 0.01% |
| Feb. 28, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 32904 | $0.00 | 314,295.0000 | 363,020,303 | 11.69% | 0.01% |
| Feb. 28, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 68243 | $0.00 | 382,538.0000 | 363,020,303 | 21.71% | 0.02% |
| Feb. 28, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | F | Common Stock | 43434 | $0.67 | 339,104.0000 | 363,020,303 | 11.35% | 0.01% |
| Feb. 28, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 25667 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| Feb. 28, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 32904 | $0.00 | 32,903.0000 | 363,020,303 | 50.00% | 0.01% |
| Feb. 28, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 68243 | $0.00 | 136,487.0000 | 363,020,303 | 33.33% | 0.02% |
| Feb. 28, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 35790 | $0.00 | 111,333.0000 | 363,020,303 | 47.38% | 0.01% |
| Feb. 28, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 74227 | $0.00 | 185,560.0000 | 363,020,303 | 66.67% | 0.02% |
| Feb. 28, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | F | Common Stock | 65308 | $0.67 | 120,252.0000 | 363,020,303 | 35.20% | 0.02% |
| Feb. 28, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 27917 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| Feb. 28, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 35790 | $0.00 | 35,790.0000 | 363,020,303 | 50.00% | 0.01% |
| Feb. 28, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 74227 | $0.00 | 148,453.0000 | 363,020,303 | 33.33% | 0.02% |
| Feb. 28, 2025 | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Common Stock | 24673 | $0.00 | 24,673.0000 | 363,020,303 | 9999.99% | 0.01% |
| Feb. 28, 2025 | DeFrancesco Lisa | SVP, IR and Corp Comm | F | Common Stock | 9096 | $0.67 | 15,577.0000 | 363,020,303 | 36.87% | 0.00% |
| Feb. 28, 2025 | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Restricted Stock Units | 24673 | $0.00 | 49,347.0000 | 363,020,303 | 33.33% | 0.01% |
| Feb. 28, 2025 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 26097 | $0.00 | 203,594.0000 | 363,020,303 | 14.70% | 0.01% |
| Feb. 28, 2025 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 33456 | $0.00 | 237,050.0000 | 363,020,303 | 16.43% | 0.01% |
| Feb. 28, 2025 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 69387 | $0.00 | 306,437.0000 | 363,020,303 | 29.27% | 0.02% |
| Feb. 28, 2025 | Crum Brian T | SVP, General Counsel & Secr. | F | Common Stock | 45622 | $0.67 | 260,815.0000 | 363,020,303 | 14.89% | 0.01% |
| Feb. 28, 2025 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 26097 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| Feb. 28, 2025 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 33456 | $0.00 | 33,457.0000 | 363,020,303 | 50.00% | 0.01% |
| Feb. 28, 2025 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 69387 | $0.00 | 138,773.0000 | 363,020,303 | 33.33% | 0.02% |
| Feb. 13, 2025 | McDermott Wendy | SVP, Human Resources | A | Restricted Stock Units | 433180 | $0.00 | 433,180.0000 | 363,020,303 | 9999.99% | 0.12% |
| Feb. 13, 2025 | Alexander Kristen | VP, Finance and Accounting | A | Restricted Stock Units | 185540 | $0.00 | 185,540.0000 | 363,020,303 | 9999.99% | 0.05% |
| Feb. 13, 2025 | Alexander Kristen | VP, Finance and Accounting | A | Stock Option (Right to Buy) | 185540 | $0.00 | 185,540.0000 | 363,020,303 | 9999.99% | 0.05% |
| Feb. 13, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | A | Restricted Stock Units | 606780 | $0.00 | 606,780.0000 | 363,020,303 | 9999.99% | 0.17% |
| Feb. 13, 2025 | Granowitz Craig B | SVP, Chief Medical Officer | A | Stock Option (Right to Buy) | 910170 | $0.00 | 910,170.0000 | 363,020,303 | 9999.99% | 0.25% |
| Feb. 13, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | A | Restricted Stock Units | 502060 | $0.00 | 502,060.0000 | 363,020,303 | 9999.99% | 0.14% |
| Feb. 13, 2025 | MAIN ALAN J | EVP, Innov & Chem Sciences | A | Stock Option (Right to Buy) | 753090 | $0.00 | 753,090.0000 | 363,020,303 | 9999.99% | 0.21% |
| Feb. 13, 2025 | McDermott Wendy | SVP, Human Resources | A | Stock Option (Right to Buy) | 649780 | $0.00 | 649,780.0000 | 363,020,303 | 9999.99% | 0.18% |
| Feb. 13, 2025 | Exton Michael | Chief Executive Officer | A | Restricted Stock Units | 1509790 | $0.00 | 1,509,790.0000 | 363,020,303 | 9999.99% | 0.42% |
| Feb. 13, 2025 | Exton Michael | Chief Executive Officer | A | Stock Option (Right to Buy) | 2264690 | $0.00 | 2,264,690.0000 | 363,020,303 | 9999.99% | 0.62% |
| Feb. 13, 2025 | Coiante Scott M | SVP, Chief Financial Officer | A | Restricted Stock Units | 480710 | $0.00 | 480,710.0000 | 363,020,303 | 9999.99% | 0.13% |
| Feb. 13, 2025 | Coiante Scott M | SVP, Chief Financial Officer | A | Stock Option (Right to Buy) | 721070 | $0.00 | 721,070.0000 | 363,020,303 | 9999.99% | 0.20% |
| Feb. 13, 2025 | Corrigan Brian | SVP, Regulatory & QA | A | Restricted Stock Units | 448660 | $0.00 | 448,660.0000 | 363,020,303 | 9999.99% | 0.12% |
| Feb. 13, 2025 | Corrigan Brian | SVP, Regulatory & QA | A | Stock Option (Right to Buy) | 673000 | $0.00 | 673,000.0000 | 363,020,303 | 9999.99% | 0.19% |
| Feb. 13, 2025 | Crum Brian T | SVP, General Counsel & Secr. | A | Restricted Stock Units | 510490 | $0.00 | 510,490.0000 | 363,020,303 | 9999.99% | 0.14% |
| Feb. 13, 2025 | Crum Brian T | SVP, General Counsel & Secr. | A | Stock Option (Right to Buy) | 765730 | $0.00 | 765,730.0000 | 363,020,303 | 9999.99% | 0.21% |
| Feb. 13, 2025 | DeFrancesco Lisa | VP, IR and Corp Comm | A | Restricted Stock Units | 384570 | $0.00 | 384,570.0000 | 363,020,303 | 9999.99% | 0.11% |
| Feb. 13, 2025 | DeFrancesco Lisa | VP, IR and Corp Comm | A | Stock Option (Right to Buy) | 576850 | $0.00 | 576,850.0000 | 363,020,303 | 9999.99% | 0.16% |
| Jan. 2, 2025 | Coiante Scott M | SVP, Chief Financial Officer | A | Stock Option (Right to Buy) | 230000 | $0.00 | 230,000.0000 | 363,020,303 | 9999.99% | 0.06% |
| Dec. 2, 2024 | Cheung Ivan | Director | A | Stock Option (Right to Buy) | 186685 | $0.00 | 186,685.0000 | 0 | 9999.99% | 0.00% |
| Aug. 12, 2024 | Corrigan Brian | SVP, Regulatory & QA | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| July 8, 2024 | WADE JEFFREY L | President and COO | A | Stock Option (Right to Buy) | 307000 | $0.00 | 307,000.0000 | 0 | 9999.99% | 0.00% |
| July 8, 2024 | Exton Michael | Chief Executive Officer | A | Stock Option (Right to Buy) | 1675000 | $0.00 | 1,675,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | Artal International S.C.A. | Not found | A | Series A Convertible Preferred Stock | 1150922 | $108.50 | 1,150,922.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | Artal International S.C.A. | Not found | M | Common Stock | 57546100 | $0.00 | 175,099,384.0000 | 0 | 48.95% | 0.00% |
| May 10, 2024 | Artal International S.C.A. | Not found | M | Series A Convertible Preferred Stock | 1150922 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 13, 2024 | Swain Judith L | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Amouyal Philippe | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Amouyal Philippe | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | BARKER SAM L | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | BARKER SAM L | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | DEBBANE RAYMOND | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | DEBBANE RAYMOND | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | LEFKOWITZ ROBERT J MD | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | LEFKOWITZ ROBERT J MD | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | SOBECKI CHRISTOPHER J | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | SOBECKI CHRISTOPHER J | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Sullivan Diane E. | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Sullivan Diane E. | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Swain Judith L | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2024 | LEFKOWITZ ROBERT J MD | Director | M | Common Stock | 8032 | $0.00 | 48,364.0000 | 0 | 19.91% | 0.00% |
| April 28, 2024 | DEBBANE RAYMOND | Director | M | Common Stock | 8032 | $0.00 | 6,800,083.0000 | 0 | 0.12% | 0.00% |
| April 28, 2024 | DEBBANE RAYMOND | Director | M | Restricted Stock Units | 8032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 28, 2024 | BARKER SAM L | Director | M | Common Stock | 8032 | $0.00 | 87,649.0000 | 0 | 10.09% | 0.00% |
| April 28, 2024 | BARKER SAM L | Director | M | Restricted Stock Units | 8032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 28, 2024 | Amouyal Philippe | Director | M | Common Stock | 8032 | $0.00 | 248,364.0000 | 0 | 3.34% | 0.00% |
| April 28, 2024 | Amouyal Philippe | Director | M | Restricted Stock Units | 8032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 28, 2024 | LEFKOWITZ ROBERT J MD | Director | M | Restricted Stock Units | 8032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 28, 2024 | SOBECKI CHRISTOPHER J | Director | M | Restricted Stock Units | 8032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 28, 2024 | SOBECKI CHRISTOPHER J | Director | M | Common Stock | 8032 | $0.00 | 167,055.0000 | 0 | 5.05% | 0.00% |
| April 28, 2024 | Swain Judith L | Director | M | Restricted Stock Units | 8032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 28, 2024 | Swain Judith L | Director | M | Common Stock | 8032 | $0.00 | 48,364.0000 | 0 | 19.91% | 0.00% |
| March 13, 2024 | Artal International S.C.A. | Not found | A | Series A Convertible Preferred Stock | 1150922 | $108.50 | 1,150,922.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | McDermott Wendy | VP, Human Resources | M | Restricted Stock Units | 18944 | $0.00 | 18,943.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | McDermott Wendy | VP, Human Resources | M | Restricted Stock Units | 27697 | $0.00 | 55,393.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 8977 | $0.00 | 221,563.0000 | 0 | 4.22% | 0.00% |
| Feb. 28, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 25666 | $0.00 | 247,229.0000 | 0 | 11.58% | 0.00% |
| Feb. 28, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 32903 | $0.00 | 280,132.0000 | 0 | 13.31% | 0.00% |
| Feb. 28, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | F | Common Stock | 24408 | $2.62 | 255,724.0000 | 0 | 8.71% | 0.00% |
| Feb. 28, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 8977 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 25666 | $0.00 | 25,667.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 32903 | $0.00 | 65,807.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 7087 | $0.00 | 126,712.0000 | 0 | 5.92% | 0.00% |
| Feb. 28, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 27556 | $0.00 | 154,268.0000 | 0 | 21.75% | 0.00% |
| Feb. 28, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 32757 | $0.00 | 187,025.0000 | 0 | 21.23% | 0.00% |
| Feb. 28, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | F | Common Stock | 24353 | $2.62 | 162,672.0000 | 0 | 13.02% | 0.00% |
| Feb. 28, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 7087 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 27556 | $0.00 | 27,557.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 32757 | $0.00 | 65,513.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 27916 | $0.00 | 43,101.0000 | 0 | 183.84% | 0.00% |
| Feb. 28, 2024 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 35790 | $0.00 | 78,891.0000 | 0 | 83.04% | 0.00% |
| Feb. 28, 2024 | Granowitz Craig B | SVP, Chief Medical Officer | F | Common Stock | 31265 | $2.62 | 47,626.0000 | 0 | 39.63% | 0.00% |
| Feb. 28, 2024 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 27916 | $0.00 | 27,917.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 35790 | $0.00 | 71,580.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 8750 | $0.00 | 143,548.0000 | 0 | 6.49% | 0.00% |
| Feb. 28, 2024 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 26096 | $0.00 | 169,644.0000 | 0 | 18.18% | 0.00% |
| Feb. 28, 2024 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 33457 | $0.00 | 203,101.0000 | 0 | 19.72% | 0.00% |
| Feb. 28, 2024 | Crum Brian T | SVP, General Counsel & Secr. | F | Common Stock | 25604 | $2.62 | 177,497.0000 | 0 | 12.61% | 0.00% |
| Feb. 28, 2024 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 8750 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 26096 | $0.00 | 26,097.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 33457 | $0.00 | 66,913.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | COATS LONNEL | Chief Executive Officer | M | Common Stock | 33333 | $0.00 | 947,692.0000 | 0 | 3.65% | 0.00% |
| Feb. 28, 2024 | COATS LONNEL | Chief Executive Officer | M | Common Stock | 91364 | $0.00 | 1,039,056.0000 | 0 | 9.64% | 0.00% |
| Feb. 28, 2024 | COATS LONNEL | Chief Executive Officer | M | Common Stock | 120383 | $0.00 | 1,159,439.0000 | 0 | 11.59% | 0.00% |
| Feb. 28, 2024 | COATS LONNEL | Chief Executive Officer | F | Common Stock | 61371 | $2.62 | 1,098,068.0000 | 0 | 5.29% | 0.00% |
| Feb. 28, 2024 | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 33333 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 91364 | $0.00 | 91,363.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 120383 | $0.00 | 240,767.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | McDermott Wendy | VP, Human Resources | F | Common Stock | 22425 | $2.62 | 52,694.0000 | 0 | 29.85% | 0.00% |
| Feb. 28, 2024 | McDermott Wendy | VP, Human Resources | M | Common Stock | 27697 | $0.00 | 75,119.0000 | 0 | 58.41% | 0.00% |
| Feb. 28, 2024 | McDermott Wendy | VP, Human Resources | M | Common Stock | 18944 | $0.00 | 47,422.0000 | 0 | 66.52% | 0.00% |
| Feb. 28, 2024 | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 49113 | $0.00 | 98,227.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 37274 | $0.00 | 37,273.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 11177 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | WADE JEFFREY L | President and CFO | F | Common Stock | 37691 | $2.62 | 324,214.0000 | 0 | 10.41% | 0.00% |
| Feb. 28, 2024 | WADE JEFFREY L | President and CFO | M | Common Stock | 49113 | $0.00 | 361,905.0000 | 0 | 15.70% | 0.00% |
| Feb. 28, 2024 | WADE JEFFREY L | President and CFO | M | Common Stock | 37274 | $0.00 | 312,792.0000 | 0 | 13.53% | 0.00% |
| Feb. 28, 2024 | WADE JEFFREY L | President and CFO | M | Common Stock | 11177 | $0.00 | 275,518.0000 | 0 | 4.23% | 0.00% |
| Feb. 28, 2024 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 15927 | $0.00 | 31,853.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2024 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 10616 | $0.00 | 10,617.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 2700 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | Alexander Kristen | VP, Finance and Accounting | F | Common Stock | 11793 | $2.62 | 47,800.0000 | 0 | 19.79% | 0.00% |
| Feb. 28, 2024 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 15927 | $0.00 | 59,593.0000 | 0 | 36.47% | 0.00% |
| Feb. 28, 2024 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 10616 | $0.00 | 43,666.0000 | 0 | 32.12% | 0.00% |
| Feb. 28, 2024 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 2700 | $0.00 | 33,050.0000 | 0 | 8.90% | 0.00% |
| Feb. 8, 2024 | McDermott Wendy | VP, Human Resources | A | Restricted Stock Units | 156950 | $0.00 | 156,950.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | WADE JEFFREY L | President and CFO | A | Restricted Stock Units | 314320 | $0.00 | 314,320.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Alexander Kristen | VP, Finance and Accounting | A | Stock Option (Right to Buy) | 59660 | $0.00 | 59,660.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Alexander Kristen | VP, Finance and Accounting | A | Restricted Stock Units | 59660 | $0.00 | 59,660.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | COATS LONNEL | Chief Executive Officer | A | Restricted Stock Units | 770420 | $0.00 | 770,420.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Crum Brian T | SVP, General Counsel & Secr. | A | Stock Option (Right to Buy) | 208160 | $0.00 | 208,160.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Crum Brian T | SVP, General Counsel & Secr. | A | Restricted Stock Units | 208160 | $0.00 | 208,160.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Garner Thomas | SVP, Chief Commercial Officer | A | Stock Option (Right to Buy) | 227130 | $0.00 | 227,130.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Garner Thomas | SVP, Chief Commercial Officer | A | Restricted Stock Units | 227130 | $0.00 | 227,130.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Granowitz Craig B | SVP, Chief Medical Officer | A | Stock Option (Right to Buy) | 222680 | $0.00 | 222,680.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Granowitz Craig B | SVP, Chief Medical Officer | A | Restricted Stock Units | 222680 | $0.00 | 222,680.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | A | Stock Option (Right to Buy) | 203810 | $0.00 | 203,810.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | A | Restricted Stock Units | 203810 | $0.00 | 203,810.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | A | Stock Option (Right to Buy) | 204730 | $0.00 | 204,730.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | MAIN ALAN J | EVP, Innov & Chem Sciences | A | Restricted Stock Units | 204730 | $0.00 | 204,730.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | McDermott Wendy | VP, Human Resources | A | Stock Option (Right to Buy) | 156950 | $0.00 | 156,950.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | COATS LONNEL | Chief Executive Officer | A | Stock Option (Right to Buy) | 770420 | $0.00 | 770,420.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | WADE JEFFREY L | President and CFO | A | Stock Option (Right to Buy) | 314320 | $0.00 | 314,320.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | COATS LONNEL | Chief Executive Officer | P | Common Stock | 90000 | $1.05 | 914,359.0000 | 0 | 10.92% | 0.00% |
| Nov. 13, 2023 | Amouyal Philippe | Director | P | Common Stock | 200000 | $1.01 | 240,332.0000 | 0 | 495.88% | 0.00% |
| Nov. 10, 2023 | COATS LONNEL | Chief Executive Officer | P | Common Stock | 10000 | $1.01 | 824,359.0000 | 0 | 1.23% | 0.00% |
| Oct. 10, 2023 | DEBBANE RAYMOND | Director | P | Common Stock | 508306 | $1.14 | 6,300,357.0000 | 0 | 8.78% | 0.00% |
| Oct. 12, 2023 | DEBBANE RAYMOND | Director | P | Common Stock | 148820 | $1.03 | 6,792,051.0000 | 0 | 2.24% | 0.00% |
| Oct. 11, 2023 | DEBBANE RAYMOND | Director | P | Common Stock | 342874 | $1.08 | 6,643,231.0000 | 0 | 5.44% | 0.00% |
| Oct. 9, 2023 | Garner Thomas | SVP, Chief Commercial Officer | A | Stock Option (Right to Buy) | 248923 | $0.00 | 248,923.0000 | 0 | 9999.99% | 0.00% |
| Sept. 14, 2023 | WADE JEFFREY L | President and CFO | P | Common Stock | 10000 | $1.38 | 264,341.0000 | 0 | 3.93% | 0.00% |
| Aug. 4, 2023 | McDermott Wendy | VP, Human Resources | P | Common Stock | 6000 | $1.84 | 28,478.0000 | 0 | 26.69% | 0.00% |
| July 27, 2023 | Sullivan Diane E. | Director | A | Stock Option (Right to Buy) | 96515 | $0.00 | 96,515.0000 | 0 | 9999.99% | 0.00% |
| June 29, 2023 | COATS LONNEL | Chief Executive Officer | P | Common Stock | 10000 | $2.16 | 814,359.0000 | 0 | 1.24% | 0.00% |
| June 23, 2023 | McDermott Wendy | VP, Human Resources | P | Common Stock | 10000 | $2.43 | 22,478.0000 | 0 | 80.14% | 0.00% |
| June 26, 2023 | COATS LONNEL | Chief Executive Officer | P | Common Stock | 10000 | $2.18 | 804,359.0000 | 0 | 1.26% | 0.00% |
| June 23, 2023 | COATS LONNEL | Chief Executive Officer | P | Common Stock | 10000 | $2.50 | 794,359.0000 | 0 | 1.27% | 0.00% |
| June 22, 2023 | COATS LONNEL | Chief Executive Officer | P | Common Stock | 40000 | $2.31 | 784,359.0000 | 0 | 5.37% | 0.00% |
| June 20, 2023 | WADE JEFFREY L | President and CFO | P | Common Stock | 10000 | $2.34 | 252,341.0000 | 0 | 4.13% | 0.00% |
| June 20, 2023 | WADE JEFFREY L | President and CFO | P | Common Stock | 2000 | $2.33 | 254,341.0000 | 0 | 0.79% | 0.00% |
| June 5, 2023 | Artal International S.C.A. | Director | P | Common Stock | 27775050 | $2.60 | 117,553,284.0000 | 0 | 30.94% | 0.00% |
| May 21, 2023 | SOBECKI CHRISTOPHER J | Director | M | Common Stock | 9302 | $0.00 | 159,023.0000 | 0 | 6.21% | 0.00% |
| May 21, 2023 | Amouyal Philippe | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | Amouyal Philippe | Director | M | Common Stock | 9302 | $0.00 | 40,332.0000 | 0 | 29.98% | 0.00% |
| May 21, 2023 | BARKER SAM L | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | BARKER SAM L | Director | M | Common Stock | 9302 | $0.00 | 79,617.0000 | 0 | 13.23% | 0.00% |
| May 21, 2023 | DEBBANE RAYMOND | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | DEBBANE RAYMOND | Director | M | Common Stock | 9302 | $0.00 | 5,792,051.0000 | 0 | 0.16% | 0.00% |
| May 21, 2023 | LEFKOWITZ ROBERT J MD | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | LEFKOWITZ ROBERT J MD | Director | M | Common Stock | 9302 | $0.00 | 40,332.0000 | 0 | 29.98% | 0.00% |
| May 21, 2023 | NIES ALAN S | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | NIES ALAN S | Director | M | Common Stock | 9302 | $0.00 | 41,046.0000 | 0 | 29.30% | 0.00% |
| May 21, 2023 | Palantoni Frank | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | Palantoni Frank | Director | M | Common Stock | 9302 | $0.00 | 40,332.0000 | 0 | 29.98% | 0.00% |
| May 21, 2023 | SOBECKI CHRISTOPHER J | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | Swain Judith L | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | Swain Judith L | Director | M | Common Stock | 9302 | $0.00 | 40,332.0000 | 0 | 29.98% | 0.00% |
| April 28, 2023 | Swain Judith L | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | Amouyal Philippe | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | Amouyal Philippe | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | BARKER SAM L | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | BARKER SAM L | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | DEBBANE RAYMOND | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | DEBBANE RAYMOND | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | LEFKOWITZ ROBERT J MD | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | LEFKOWITZ ROBERT J MD | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | NIES ALAN S | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | NIES ALAN S | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | Palantoni Frank | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | Palantoni Frank | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | SOBECKI CHRISTOPHER J | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | SOBECKI CHRISTOPHER J | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | Swain Judith L | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 26097 | $0.00 | 155,335.0000 | 0 | 20.19% | 0.00% |
| Feb. 28, 2023 | Alexander Kristen | VP, Finance and Accounting | F | Common Stock | 5330 | $2.17 | 30,350.0000 | 0 | 14.94% | 0.00% |
| Feb. 28, 2023 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 5400 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 2700 | $0.00 | 2,700.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 10617 | $0.00 | 21,233.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | Seth Kiernan | VP, Chief Commercial Officer | M | Common Stock | 14833 | $0.00 | 36,700.0000 | 0 | 67.83% | 0.00% |
| Feb. 28, 2023 | Seth Kiernan | VP, Chief Commercial Officer | M | Common Stock | 5286 | $0.00 | 41,986.0000 | 0 | 14.40% | 0.00% |
| Feb. 28, 2023 | Seth Kiernan | VP, Chief Commercial Officer | M | Common Stock | 22963 | $0.00 | 64,949.0000 | 0 | 54.69% | 0.00% |
| Feb. 28, 2023 | Seth Kiernan | VP, Chief Commercial Officer | F | Common Stock | 11813 | $2.17 | 53,136.0000 | 0 | 18.19% | 0.00% |
| Feb. 28, 2023 | Seth Kiernan | VP, Chief Commercial Officer | M | Restricted Stock Units | 14833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | Seth Kiernan | VP, Chief Commercial Officer | M | Restricted Stock Units | 5286 | $0.00 | 5,287.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | Seth Kiernan | VP, Chief Commercial Officer | M | Restricted Stock Units | 22963 | $0.00 | 45,927.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | McDermott Wendy | VP, Human Resources | M | Common Stock | 18943 | $0.00 | 18,943.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | McDermott Wendy | VP, Human Resources | F | Common Stock | 6465 | $2.17 | 12,478.0000 | 0 | 34.13% | 0.00% |
| Feb. 28, 2023 | McDermott Wendy | VP, Human Resources | M | Restricted Stock Units | 18943 | $0.00 | 37,887.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 23300 | $0.00 | 198,889.0000 | 0 | 13.27% | 0.00% |
| Feb. 28, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 8976 | $0.00 | 207,865.0000 | 0 | 4.51% | 0.00% |
| Feb. 28, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Common Stock | 25667 | $0.00 | 233,532.0000 | 0 | 12.35% | 0.00% |
| Feb. 28, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | F | Common Stock | 20946 | $2.17 | 212,586.0000 | 0 | 8.97% | 0.00% |
| Feb. 28, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 23300 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 8976 | $0.00 | 8,977.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | M | Restricted Stock Units | 25667 | $0.00 | 51,333.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 18243 | $0.00 | 104,100.0000 | 0 | 21.25% | 0.00% |
| Feb. 28, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 7086 | $0.00 | 111,186.0000 | 0 | 6.81% | 0.00% |
| Feb. 28, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 27557 | $0.00 | 138,743.0000 | 0 | 24.78% | 0.00% |
| Feb. 28, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | F | Common Stock | 19118 | $2.17 | 119,625.0000 | 0 | 13.78% | 0.00% |
| Feb. 28, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 18243 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 7086 | $0.00 | 7,087.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 27557 | $0.00 | 55,113.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | Granowitz Craig B | SVP, Chief Medical Officer | M | Common Stock | 27917 | $0.00 | 27,917.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Granowitz Craig B | SVP, Chief Medical Officer | F | Common Stock | 12732 | $2.17 | 15,185.0000 | 0 | 45.61% | 0.00% |
| Feb. 28, 2023 | Granowitz Craig B | SVP, Chief Medical Officer | M | Restricted Stock Units | 27917 | $0.00 | 55,833.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 21030 | $0.00 | 120,488.0000 | 0 | 21.14% | 0.00% |
| Feb. 28, 2023 | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 8750 | $0.00 | 129,238.0000 | 0 | 7.26% | 0.00% |
| Feb. 28, 2023 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 10617 | $0.00 | 35,680.0000 | 0 | 42.36% | 0.00% |
| Feb. 28, 2023 | Crum Brian T | SVP, General Counsel & Secr. | F | Common Stock | 20537 | $2.17 | 134,798.0000 | 0 | 13.22% | 0.00% |
| Feb. 28, 2023 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 21030 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 8750 | $0.00 | 8,750.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 26097 | $0.00 | 52,193.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | WADE JEFFREY L | President and CFO | M | Common Stock | 30467 | $0.00 | 224,147.0000 | 0 | 15.73% | 0.00% |
| Feb. 28, 2023 | WADE JEFFREY L | President and CFO | M | Common Stock | 11176 | $0.00 | 235,323.0000 | 0 | 4.99% | 0.00% |
| Feb. 28, 2023 | WADE JEFFREY L | President and CFO | M | Common Stock | 37273 | $0.00 | 272,596.0000 | 0 | 15.84% | 0.00% |
| Feb. 28, 2023 | WADE JEFFREY L | President and CFO | F | Common Stock | 30255 | $2.17 | 242,341.0000 | 0 | 11.10% | 0.00% |
| Feb. 28, 2023 | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 30467 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 11176 | $0.00 | 11,177.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 37273 | $0.00 | 74,547.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | COATS LONNEL | Chief Executive Officer | M | Common Stock | 84630 | $0.00 | 670,633.0000 | 0 | 14.44% | 0.00% |
| Feb. 28, 2023 | COATS LONNEL | Chief Executive Officer | M | Common Stock | 33334 | $0.00 | 703,967.0000 | 0 | 4.97% | 0.00% |
| Feb. 28, 2023 | COATS LONNEL | Chief Executive Officer | M | Common Stock | 91363 | $0.00 | 795,330.0000 | 0 | 12.98% | 0.00% |
| Feb. 28, 2023 | COATS LONNEL | Chief Executive Officer | F | Common Stock | 50971 | $2.17 | 744,359.0000 | 0 | 6.41% | 0.00% |
| Feb. 28, 2023 | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 84630 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 33334 | $0.00 | 33,333.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | COATS LONNEL | Chief Executive Officer | M | Restricted Stock Units | 91363 | $0.00 | 182,727.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 5400 | $0.00 | 22,363.0000 | 0 | 31.83% | 0.00% |
| Feb. 28, 2023 | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 2700 | $0.00 | 25,063.0000 | 0 | 12.07% | 0.00% |
| Feb. 9, 2023 | WADE JEFFREY L | President and CFO | A | Stock Option (Right to Buy) | 442030 | $0.00 | 442,030.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | WADE JEFFREY L | President and CFO | A | Restricted Stock Units | 147340 | $0.00 | 147,340.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Crum Brian T | SVP, General Counsel & Secr. | A | Stock Option (Right to Buy) | 301100 | $0.00 | 301,100.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Crum Brian T | SVP, General Counsel & Secr. | A | Restricted Stock Units | 100370 | $0.00 | 100,370.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Granowitz Craig B | SVP, Chief Medical Officer | A | Stock Option (Right to Buy) | 322110 | $0.00 | 322,110.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Granowitz Craig B | SVP, Chief Medical Officer | A | Restricted Stock Units | 107370 | $0.00 | 107,370.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | A | Stock Option (Right to Buy) | 294810 | $0.00 | 294,810.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | A | Restricted Stock Units | 98270 | $0.00 | 98,270.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | A | Stock Option (Right to Buy) | 296130 | $0.00 | 296,130.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | MAIN ALAN J | EVP, Innov & Chem Sciences | A | Restricted Stock Units | 98710 | $0.00 | 98,710.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | McDermott Wendy | VP, Human Resources | A | Stock Option (Right to Buy) | 249280 | $0.00 | 249,280.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | McDermott Wendy | VP, Human Resources | A | Restricted Stock Units | 83090 | $0.00 | 83,090.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Seth Kiernan | VP, Chief Commercial Officer | A | Stock Option (Right to Buy) | 280100 | $0.00 | 280,100.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Seth Kiernan | VP, Chief Commercial Officer | A | Restricted Stock Units | 93370 | $0.00 | 93,370.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Alexander Kristen | VP, Finance and Accounting | A | Stock Option (Right to Buy) | 71670 | $0.00 | 71,670.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Alexander Kristen | VP, Finance and Accounting | A | Restricted Stock Units | 47780 | $0.00 | 47,780.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | COATS LONNEL | Chief Executive Officer | A | Stock Option (Right to Buy) | 1083440 | $0.00 | 1,083,440.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | COATS LONNEL | Chief Executive Officer | A | Restricted Stock Units | 361150 | $0.00 | 361,150.0000 | 0 | 9999.99% | 0.00% |